These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Immunological activation of oncogenic viruses: interrelationship of immunostimulation and immunosuppression. Hirsch MS Johns Hopkins Med J Suppl; 1974; 3():177-85. PubMed ID: 4153909 [No Abstract] [Full Text] [Related]
8. Alloantisera reacting with tumor cells of inappropriate haplotype. I. Characterization of target antigens. Prat M; Rogers MJ; Appella E J Natl Cancer Inst; 1978 Aug; 61(2):527-34. PubMed ID: 79659 [No Abstract] [Full Text] [Related]
9. [Thymus and carcinogenesis. The genetic aspect of the problem]. Gruntenko EV Usp Sovrem Biol; 1973; 75(2):278-94. PubMed ID: 4574951 [No Abstract] [Full Text] [Related]
10. Depression of antilymphoma allograft reactivity by tumor-associated factors. Bonmassar E; Bonmassar A; Goldin A; Cudkowicz G Cancer Res; 1973 May; 33(5):1054-61. PubMed ID: 4703118 [No Abstract] [Full Text] [Related]
12. [Blood lymphocytes in cancer]. Shats VIa Tsitologiia; 1972 Jan; 14(1):3-12. PubMed ID: 4551781 [No Abstract] [Full Text] [Related]
13. Immunological reactions to tumor-associated antigens in Burkitts lymphoma and other lymphomas. Herberman RB; McCoy JL; Levine PH Cancer Res; 1974 May; 34(5):1222-7. PubMed ID: 4366992 [No Abstract] [Full Text] [Related]
14. Combined neoplastic effects of vaccinia virus and 3-methylcholanthrene. I. Studies with mice of different inbred strains. Duran-Reynals ML J Natl Cancer Inst; 1972 Jan; 48(1):95-104. PubMed ID: 4652378 [No Abstract] [Full Text] [Related]
15. Drug-mediated changes of tumour cell immunogenicity and antigenicity. Puccetti P; Romani L; Taramelli D; Bonmassar E; Fioretti MC Int J Tissue React; 1982; 4(3):189-99. PubMed ID: 6183194 [No Abstract] [Full Text] [Related]
16. Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts. Kerbel RS Biomedicine; 1974 Jul; 21(7):253-61. PubMed ID: 4547979 [No Abstract] [Full Text] [Related]
17. Immune reactivity to tumor antigens in leukemia and lymphoma. Leventhal BG; Mirro J; Yarbro GS Semin Hematol; 1978 Apr; 15(2):157-79. PubMed ID: 148730 [No Abstract] [Full Text] [Related]
18. [Importance of specific and nonspecific immunity in anti-tumor defense]. Biozzi G; Stiffel C; Mouton D; Bouthillier Y; Decreusefond C Ann Inst Pasteur (Paris); 1972 Apr; 122(4):685-94. PubMed ID: 5050875 [No Abstract] [Full Text] [Related]
19. Delayed cutaneous hypersensitivity to oxazolone in mice with tumors. Hemsworth GR; Wolff JS; Kraska AR; Jensen KE Cancer Res; 1978 Apr; 38(4):907-10. PubMed ID: 639044 [TBL] [Abstract][Full Text] [Related]
20. [Immunologic response to transplantable specific antigens in experimental tumors]. Porwit-Bóbr Z Postepy Hig Med Dosw; 1971; 25(1):25-36. PubMed ID: 4932042 [No Abstract] [Full Text] [Related] [Next] [New Search]